首页 / 院系成果 / 成果详情页

Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity  期刊论文  

  • 编号:
    4f9ab8f3-bd3e-4600-8e73-edafdd51b152
  • 作者:
    Ding, Guanxiong[1];Wang, Jianqing[1];Feng, Chenchen(冯陈陈)[1]Jiang, Haowen(姜昊文)[1]Xu, Jianfeng[1,2];Ding, Qiang(丁强)[1]
  • 语种:
    English
  • 期刊:
    ONCOTARGET ISSN:1949-2553 2016 年 7 卷 39 期 (64309 - 64317) ; SEP 27
  • 收录:
  • 关键词:
  • 摘要:

    Background: Castration-resistant prostate cancer (CRPC) is the lethal phenotype of prostate cancer. Lipocalin 2 (LCN2) is aberrantly expressed in many cancers including primary prostate cancer (PCa), but its role in CRPC has not been reported. Results: LCN2 expression was upregulated in human primary PCa and CRPC tissues. Overexpression of LCN2 promoted C4-2B and 22RV1 cell proliferation while knockdown of LCN2 markedly inhibited C4-2B and 22RV1 cell growth. LCN2 overexpression led to increased AR downstream gene SLC45A3 without upregulating AR expression. In the xenograft model, overexpression of LCN2 significantly promoted tumor growth. Methods: LCN2 expression was detected in primary PCa and CRPC tissues and cell lines C4-2B and 22RV1 using immunohistochemistry and western blotting, respectively. Serum LCN2 level was detected vi ELISA. Lentiviruses-mediated over-expression of LCN2 and LCN2 knockdown were performed in CRPC cell lines. Expressions of androgen receptor(AR) downstream genes was examined in cell lines, in CRPC tissues, and in animal models. Conclusion: LCN2 could facilitate cell proliferation of CRPC via AR transcriptional activity. LCN2 could be a novel target in CRPC.

  • 推荐引用方式
    GB/T 7714:
    Ding Guanxiong,Wang Jianqing,Feng Chenchen, et al. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity [J].ONCOTARGET,2016,7(39):64309-64317.
  • APA:
    Ding Guanxiong,Wang Jianqing,Feng Chenchen,Jiang Haowen,&Ding Qiang.(2016).Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity .ONCOTARGET,7(39):64309-64317.
  • MLA:
    Ding Guanxiong, et al. "Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity" .ONCOTARGET 7,39(2016):64309-64317.
浏览次数:5 下载次数:0
浏览次数:5
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部